Levo-LC Tablet is a combination medication containing Levocetirizine 5 mg and Montelukast 10 mg, formulated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedative antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms like sneezing, nasal congestion, and itching. Montelukast, a leukotriene receptor antagonist, blocks leukotriene D4 receptors in the airways, preventing bronchoconstriction, inflammation, and mucus production associated with allergic responses and asthma. The synergistic action of these two agents provides comprehensive relief from allergic symptoms by targeting different inflammatory pathways. Levo-LC Tablet is indicated for patients requiring effective control of seasonal or perennial allergic rhinitis and asthma prophylaxis. It is generally well-tolerated, with a low incidence of adverse effects such as headache, dry mouth, or gastrointestinal discomfort. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision in pregnant or lactating women. This combination therapy offers a convenient once-daily dosing regimen, improving patient compliance and quality of life in managing allergic disorders.

Dosage & How to Use